Arab, Middle East News and Press release distribution
Arab & Middle East News and Press Release Distribution Services

Home | News | About Us | Contact Us


 


 
Press Releases | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

News Media




Al Bawaba
Al Jazeera
Al Monitor
AMEinfo
Arabian Business
Arabian Gazette
Arab News
Arab Times
BBC Middle East
Emirates247
Gulf News
KippReport
Memri
Middle East Forum
New York Times
Press Display
The Jerusalem Post
The National
VOA Middle East
Yahoo! Maktoob
Zawya

Arab & Middle East News

Autoinjectors Market 2020 Research Analysis | Abbvie, Teva, Eli Lilly

 



(ARABNEWSWIRE.COM, June 27, 2020 ) Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.



The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).



Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) – Global Forecast to 2023



In terms of Therapy, the global autoinjectors market can be segmented into:



1. Rheumatoid Arthritis

2. Multiple Sclerosis

3. Diabetes

4. Anaphylaxis

5. Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia)



By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018



On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies such as migraines, cardiovascular diseases, psoriasis, and anemia. In 2018, the rheumatoid arthritis segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.



Get a sample PDF copy of the Report @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724



Autoinjectors are easy-to-handle and cost-effective medical devices that can be used by patients, caregivers, and even untrained personnel to deliver a dose of a particular drug. Autoinjectors are used by patients to manage autoimmune diseases and chronic diseases. They are used for a wide range of indications such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis.



The geographical regions mapped in the report are:



1. North America

2. Europe

3. APAC

4. Rest of the World



North America to dominate the market in 2018

In 2018, North America is expected to account for the largest share of the autoinjectors market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, rising prevalence of anaphylaxis in the US, and rising prevalence of autoimmune and chronic diseases in the US and Canada are contributing to the large share of North America.



Leading players of Autoinjectors Market including:



Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US) Merck (US), SHL Group (Taiwan), Ypsomed (Switzerland), AstraZeneca (UK), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), J&J (US), Haselmeier (Switzerland), Consort Medical (France), Antares Pharma (US)



Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

MarketsandMarkets™

Mr. Aashish Mehra

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Arab News by Countries






Arab & Middle East Resource Center
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Governing
Point of Beginning
Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

No credit cards, coupons, or promo codes required. Try it today!

Press release service

ArabNewsWire.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
Copyright 2008 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
ArabNewsWire.Com - Newswire and Press Release service of GroupWeb Media LLC